Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 1,525 shares at $100.00 ($153K) on 2021-12-07, disclosed to the SEC on 2021-12-08.
Open-market sale of $152k HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| HZNP | SELL | 2022-07-29 | $801K | — | Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |